Article
A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk.
Journal of cancer research and clinical oncology - 1 Feb 2013
Chen Jun, Liu Reng-Yun, Yang Lixin, Zhao Jun, Zhao Xueying, Lu Daru, Yi Nengjun, Han Baohui, Chen Xiao-Feng, Zhang Kui, He Jun, Lei Zhe, Zhou Yifeng, Pasche Boris, Li Xiangdong, Zhang Hong-Tao
Abstract excerpt
BACKGROUND: Aberrant expression of interleukin-6 (IL-6) may play an important role in lung carcinogenesis. Whether IL-6 promoter haplotypes are associated with lung cancer risk and their functions have not yet been studied. We tested the hypothesis that single-nucleotide polymorphism (SNP) and/or haplotypes of IL-6 promoter are associated with risk of lung cancer. METHODS: Two functional IL-6 promoter SNPs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
